[DHR] Danaher Corporation

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Industrial Machinery/Components

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 78.94 Change: 0.61 (0.78%)
Ext. hours: Change: 0 (0%)

chart DHR

Refresh chart

Strongest Trends Summary For DHR

DHR is in the medium-term up 12% above S&P in 7 months. In the long-term up 338% in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company?s Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; network monitoring, management, and optimization tools; and security solutions for communications and enterprise networks. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet management. The company?s Life Sciences & Diagnostics segment provides various research and clinical tools for scientists to study cells and its components; and a range of analytical instruments, reagents, consumables, software, and services for hospitals, physician?s offices, reference laboratories

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters-1.72% EPS Growth - Q/Q20.16%
EPS Growth - Y/Y-10.3% Sales Growth - 4 Quarters 5.27% Sales Growth - Q/Q5.21% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA7.05% ROE10.82% ROI8.18%
Current Ratio1.91 Quick Ratio1.53 Long Term Debt/Equity0.66 Debt Ratio0.21
Gross Margin52.89% Operating Margin17.05% Net Profit Margin12.85% Dividend Payout Ratio-11.74%
Dividend Yield
Fundamental Data
Cash From Financing Activities-299.4 M Cash From Investing Activities-937.6 M Cash From Operating Activities1.62 B Gross Profit2.76 B
Net Profit695.6 M Operating Profit931.1 M Total Assets36.99 B Total Current Assets9.65 B
Total Current Liabilities5.06 B Total Debt3.16 B Total Liabilities12.89 B Total Revenue5.13 B
Technical Data
High 52 week109.37 Low 52 week91.86 Last close104.49 Last change-0.52%
RSI62.13 Average true range2.33 Beta0.89 Volume1.17 M
Simple moving average 20 days2.95% Simple moving average 50 days2.03% Simple moving average 200 days2.68%
Performance Data
Performance Week0.12% Performance Month4.24% Performance Quart2.61% Performance Half5.09%
Performance Year5.22% Performance Year-to-date1.33% Volatility daily2.01% Volatility weekly4.49%
Volatility monthly9.2% Volatility yearly31.86% Relative Volume230.45% Average Volume2.86 M
New High New Low

News

2019-03-18 09:05:01 | Danaher to Gain From Solid Demand in Key Markets Amid Risks

2019-03-12 10:25:34 | See what the IHS Markit Score report has to say about Danaher Corp.

2019-03-11 08:34:32 | Why General Electric Stock Plunged ~7% Last Week

2019-03-11 05:01:42 | Too Early or Too Late? General Electric Stock Has Investors Guessing

2019-03-08 16:15:00 | Danaher Announces Quarterly Dividend

2019-03-08 08:00:00 | What the GE-Danaher Deal Means to Both Sets of Investors

2019-03-07 08:10:35 | GE Fell ~8% after J.P. Morgan Warned of More Downside Risk

2019-03-06 22:44:02 | [$$] The Investors Who Bet Big on GE

2019-03-06 11:31:17 | Has the Turnaround of GE Stock Already Come and Gone?

2019-03-06 09:27:00 | GE's stock tumbles again after downbeat cash flow outlook and analyst call

2019-03-06 08:20:00 | Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics — Future Expectations, Projections Moving into 2019

2019-03-05 02:26:34 | How Corporate America's New Debt Diet Will Boost Stocks

2019-03-04 15:13:31 | Healthcare ETF Keeps Hitting New Highs

2019-03-04 10:30:00 | GE Stock Could Almost Double to $20, Says Analyst

2019-03-04 08:53:00 | Will Danaher Corporation’s NYSE:DHR Earnings Grow In The Next 12 Months?

2019-03-04 07:18:12 | Danaher's Stock Offering Proceeds to Fund BioPharma Buyout

2019-03-01 17:00:00 | Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

2019-03-01 16:00:25 | GE Nuggets to Chew on From Its Annual Report

2019-02-28 12:45:00 | GE's stock sinks to pace industrial sector's losers; set to snap 4-day win streak

2019-02-28 11:08:19 | Is Larry Culp Leading General Electric In the Right Direction?

2019-02-28 08:24:01 | GE Intends to Lower Debt Burden, Boost Dividend Payments

2019-02-27 10:28:46 | GE Soared after Larry Culp Stresses Debt Cut and Dividend Boost

2019-02-27 09:48:00 | General Electric Biopharma Sale Helps Debt Reduction, Hurts Earnings - JPM Tusa

2019-02-27 08:03:46 | GE Shares Rose 2.5%, Analysts Turned Bullish on the Stock

2019-02-27 05:29:50 | Health care is once again part of GE’s future, Culp tells investors

2019-02-26 23:15:00 | Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

2019-02-26 10:54:34 | GE shares jump again as Wall Street loves Danaher deal: Stock no longer has 'downside risk'

2019-02-26 09:49:02 | Danaher to Buy BioPharma, Offers Common & Preferred Shares

2019-02-26 09:47:02 | General Electric GE to Divest BioPharma, Closes Wabtec Deal

2019-02-26 09:30:02 | Company News For Feb 26, 2019

2019-02-26 09:13:38 | Tuesday’s Vital Data: General Electric, Alibaba and Cisco

2019-02-26 08:54:01 | Danaher DHR Catches Eye: Stock Jumps 8.5%

2019-02-26 07:12:00 | How General Electric and Danaher Created $16 Billion in Market Value With Just One Deal

2019-02-25 20:02:00 | Has General Electric Officially Turned the Corner?

2019-02-25 19:50:34 | [$$] GE to Sell Its Biotech Business to Danaher for $21 Billion

2019-02-25 19:26:00 | GE's Big Debt Problem Just Disappeared

2019-02-25 17:12:00 | Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

2019-02-25 16:31:00 | Why Danaher, CRISPR Therapeutics, and Clementia Pharmaceuticals Jumped Today

2019-02-25 16:25:54 | GE Surges After Agreeing to $21.4 Billion Sale of BioPharma Unit

2019-02-25 16:20:00 | General Electric Shares Surge After Selling BioPharma Unit to Danaher

2019-02-25 16:08:58 | Danaher To Buy GE Biopharma For $21.4 Billion — But A Key IPO Is Now In Doubt

2019-02-25 16:06:00 | Dow Closes Modestly Higher After Trump Extends China Tariff Deadline

2019-02-25 15:59:38 | 5 Top Stock Trades for Tuesday: S&P 500, Amazon and Danaher

2019-02-25 15:15:23 | GE Puts Debt Cuts in Forefront With $21 Billion Asset Sale

2019-02-25 13:55:06 | Pre-Markets Up, GE Sells Off Biopharma Biz

2019-02-25 13:46:37 | GE debt rallies, bond insurance price drops on Danaher deal

2019-02-25 13:01:49 | Buffett Missing in Action as GE’s Turnaround Plan Gets Upvote

2019-02-25 12:19:36 | GE Healthcare spinoff likely shelved for 2019

2019-02-25 12:18:10 | Danaher Stock Surges on GE Biopharma Deal

2019-02-25 12:14:00 | Why General Electric Stock Popped 15% This Morning